This research study used both primary and secondary sources. The research process involved examining various aspects that impact the industry, including segmentation types, industry trends, leading participants, the competitive landscape, major market dynamics, and the strategies employed by key market players.
Secondary Research
Secondary research extensively utilizes various secondary sources, including directories, databases (such as Bloomberg Business, D&B Hoovers, and Factiva), white papers, annual reports, company documents, investor presentations, and SEC filings related to companies. This research method helps gather and organize both general and technical data pertinent to the market study and commercial analysis of breast biopsy devices. It also collects crucial information about key players, market taxonomy, and segmentation according to industry trends, down to the foundational level, as well as significant developments concerning market and technology perspectives. Additionally, secondary research has created a database of key industry leaders.
Primary Research
Various supply and demand sources were interviewed during the primary research process to collect both qualitative and quantitative information for this report. Key professionals involved in biopsy techniques and device usage include radiologists, breast surgeons, interventional radiologists, and oncologists. Insights are also gathered from hospital procurement managers, biomedical engineers, and department heads regarding purchasing decisions, product preferences, and barriers to adoption. On the industry side, product managers, sales directors, and R&D leaders from medical device companies provide perspectives on innovation, competition, and market dynamics. The aim of this primary research is to validate market segmentation, identify major players in the market, and gain insights into key industry trends and dynamics.
A breakdown of the primary respondents is provided below:
Note 1: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 2: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = < USD 50 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
This report analyzes the market size for breast biopsy devices based on estimated revenue figures from 15 major market players. To determine the market size, we first identified the key players and then derived their revenues using insights gathered from both primary and secondary research. The secondary research involved analyzing financial and annual reports from these key players, while the primary research included interviews with key opinion leaders (KOLs), such as CEOs, directors, and marketing leaders.
This report outlines a process that calculates segment revenues and projects them onto the global market value by using revenue mappings. These mappings helped create geographic and strategically defined segments based on data from large solutions and service providers. The process included:
-
Compiling a list of key global players in the breast biopsy devices market.
-
Mapping the annual revenues generated from the market (or the closest reported business unit/product category) for these major global players.
-
Analyzing the revenue distribution among key players to determine their market share in the global market as of 2024.
-
Estimating the global value of the breast biopsy devices market.
Global Breast Biopsy Devices Market: Top-down Approach and Bottom-up Approach
Data Triangulation
After determining the total market size through the previously outlined process, the breast biopsy devices market was divided into segments and subsegments. We used data triangulation and market breakdown methodologies to complete the market engineering process and calculate the precise figures for all segments and subsegments. This data was validated by analyzing various parameters and trends, including both demand and supply. Additionally, the breast biopsy devices market was validated using a combination of top-down and bottom-up approaches.
Market Definition
The breast biopsy devices market encompasses the global industry involved in designing, manufacturing, and distributing medical devices and technologies used to obtain tissue samples from the breast. This process is typically conducted to perform diagnostic testing and determine whether any cancerous or abnormal growths are present.
This market includes various biopsy techniques, such as core needle biopsy, fine needle aspiration, and vacuum-assisted biopsy, as well as surgical biopsy methods. Additionally, it comprises the imaging guidance systems necessary for performing biopsies, including ultrasound, MRI, and stereotactic systems.
The breast biopsy devices market serves a range of institutions, including hospitals, surgical centers, diagnostic laboratories, and research organizations. The demand for accurate, minimally invasive, and early diagnosis of breast cancer is continuously increasing.
Factors that influence the breast biopsy market include technological advancements, the rising incidence of breast cancer, and government-funded screening programs.
Stakeholders
-
Manufacturers and distributors of breast biopsy needles, assay kits, and devices
-
Healthcare institutions
-
Research institutions
-
Research and consulting firms
-
Medical device suppliers, distributors, channel partners, and third-party suppliers
-
Clinicians and healthcare professionals
-
Global and national health agencies
-
Academic medical centers and universities
-
Contract research organizations (CROs) and contract manufacturing organizations (CMOs)
-
Academic medical centers and universities
-
Market research and consulting firms
-
Group Purchasing Organizations (GPOs)
-
Accountable Care Organizations (ACOs)
Report Objectives
-
To define, describe, and forecast the breast biopsy devices market by product, procedure, application, and end user
-
To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
-
To strategically analyze the micromarkets concerning individual growth trends, prospects, and contributions to the total market
-
To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
-
To profile the key market players and comprehensively analyze their market shares and core competencies
-
To forecast the revenue of the market segments concerning five main regions: North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), the Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), and the Middle East & Africa (GCC Countries and the Rest of Middle East & Africa)
-
To track and analyze competitive developments such as new product launches & approvals; agreements, partnerships, expansions, acquisitions; and collaborations in the breast biopsy devices market
HIGHEST CAGR MARKET IN 2025–2030
CHINA: FASTEST-GROWING MARKET IN THE REGION
Growth opportunities and latent adjacency in Breast Biopsy Devices Market